Analysis of drug-eluting stents data demonstrates safety, efficacy in on-and-off-label use
NEW YORK, NY JUNE 16, 2009 The Cardiovascular Research Foundation (CRF) announced that results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents
(DES) versus bare metal stents
(BMS) were published online June 15 in the journal Circulation . The study also co...
NEJM study finds drug-eluting stents more effective than bare-metal stents in heart attack patients
NEW YORK (May 26, 2009) -- NewYork-Presbyterian Hospital and Columbia University Medical Center, together with the Cardiovascular Research Foundation (CRF), announced that its landmark study comparing the safety and efficacy of drug-eluting stents
and bare-metal stents
was published in the May 7 ...
CorNova to Present at the Glimpse into the Future: Emerging Drug-Eluting Stents Symposium at EuroPCR 2009
S. Eric Ryan, M.D., Will Discuss the Valecor Platinum(TM) Coronary Stent System on the FiberHalo(TM) Balloon Angioplasty Catheter
BURLINGTON, Mass., May 14 /PRNewswire/ -- CorNova Inc. today announced S. Eric Ryan, M.D., the company's chairman and chief executive officer, will present the Val...
Drug-Coated Stents Better at Keeping Arteries Open
But they show no lifesaving benefit over bare-metal version, studies show
WEDNESDAY, May 6 (HealthDay News) -- Although arteries propped open by drug-coated stents
are less likely to become blocked again than those treated with bare-metal stents, the risk of death and heart attacks is...
Appeals Court Affirms That J&J Stents Infringe Boston Scientific Patent; Claims Against TAXUS Liberte Dismissed
NATICK, Mass., March 31 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) announced today that the Court of Appeals for the Federal Circuit issued a decision in the Company's stent litigation with Johnson and Johnson (J&J).
The Court of Appeals upheld the District C...
No Increase in Clots With Drug-Eluting Stents
Risk appears the same for bare metal or drug-eluting devices, study found,,
SUNDAY, March 29 (HealthDay News) -- Despite initial concerns that stent thrombosis, a blood clot inside a stent, is more common with the drug-eluting device, there appears to be no difference in the clot risk ...
Drug-eluting stents found safe, superior to bare metal stents
DURHAM, NC Drug-eluting stents
were safe and superior to bare metal stents
in preventing death and heart attacks among 262,700 "real-world" patients enrolled in a nationwide registry of cardiovascular disease, according to researchers from Duke University Medical Center.
The findings were pre...
Bioabsorbable stents show promise
A study published today online in The Lancet (March 13, 2009) presented two year data for the bioabsorbable everolimus coronary stent. Commenting on the results, interventional cardiology specialist, Professor Franz Eberli from the University Hospital Zurich (Switzerland) and official spokespers...
Drugs Before Stents for Stable Heart Disease, Study Says
Most important, expert says, is to aggressively try to reduce risk factors,,,,,,
THURSDAY, March 12 (HealthDay News) -- Treating people with non-acute heart problems should start with drug therapy, not invasive techniques such as angioplasty or implanting stents, because there is no di...
Drug-Eluting Stents Show Promise for Leg Arteries
Fewer repeat procedures were needed in people with peripheral arterial disease, study finds,,
TUESDAY, March 10 (HealthDay News) -- Treating peripheral arterial disease with drug-eluting stents
may save lives and limbs in people with severely obstructed arteries, Greek researchers have...
Efficacy of stents is improved when their placement is determined by arterial blood flow measurement
Reperfusion therapy in the form of percutaneous coronary intervention (PCI) is now the recommended first treatment for victims of acute myocardial infarction. New European guidelines issued in November 2008 emphasised speed of action and the importance of reperfusion therapy to restore blood flow ...
UT Southwestern researchers find drug-coated stents less risky for heart bypass patients
DALLAS Jan. 22, 2009 Coronary bypass surgery may carry less risk of serious complications if stents
coated with a drug that suppresses cell growth are used in the procedure rather than bare-metal stents, UT Southwestern Medical Center researchers and colleagues have found.
The study, appearin...
Coated Stents Better Than Bare Metal Ones in Short Run
But slightly higher mortality rates showed up after 3 years, study finds
THURSDAY, Dec. 18 (HealthDay News) -- Angioplasty patients who receive stents
coated with medication to prevent narrowing of the artery do better one year after the surgery than those who receive bare metal stents...
Drug-Eluting Stents Beat Bare Metal Stents in Diabetics
-- Drug-eluting stents
showed improved outcomes as compared with bare
-- No excess adverse events were found with drug-eluting stents
NEW ORLEANS, Nov. 11 /PRNewswire-USNewswire/ -- Drug-eluting stents
reduced the risk of...
Coated Stents Best for Heart Patients With Diabetes
Were safer, more effective than bare metal ones, study shows
MONDAY, Nov. 10 (HealthDay News) -- Drug-coated stents
appear to be superior to bare metal stents
in both efficacy and safety in patients with diabetes, new research shows.
"I would say consistently from randomized trials ...
Drug-Coated Stents Reduce Repeat Artery Procedures
But sicker patients may be getting bare metal devices, study suggests
TUESDAY, June 24 (HealthDay News) -- Heart patients who got drug-coated stents
did better than those who received the bare-metal kind of stent, a major study found.
But it isn't a simple either-or issue, the study...
More patients with drug-coated cardiac stents survive, avoid costly follow-up procedures
(PHILADELPHIA) The more than ten million Americans whove received drug-eluting stents
to open their blocked coronary arteries have a bright future, according to new research from the University of Pennsylvania School of Medicine.
The findings, among the first large follow-up studies to show a...
Drug-Coated Stents Still Spark Debate
Doctors divided on the risks posed by the artery-opening devices
FRIDAY, May 9 (HealthDay News) -- Stents
have become a cornerstone of heart-disease treatment, tiny tools that have extended the lives of millions of patients by maintaining the flow of blood through their arteries.
Drug-Eluting Stents Safe After Heart Attack
Long-term study indicates they lower restenosis risk and don't increase mortality probability
SUNDAY, March 30 (HealthDay News) -- Drug-eluting stents, the small tubing placed in diseased coronary arteries to keep them open, are more effective than bare-metal stents
for heart attack pa...
Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases
Survival advantage found in 'off-label' uses, report suggests
MONDAY, Feb. 4 (HealthDay News) -- Drug-coated stents
are better than the bare-metal kind for treating complex arterial blockages, new research finds.
"There are two messages I would take away from the study," said Dr. R...
Study Finds Both Coated Stents Perform the Same
Incidence of major adverse events was also lower than researchers anticipated
TUESDAY, Jan. 29 (HealthDay News) -- In a large study comparing the real-life effectiveness of two different drug-coated stents, Danish researchers found no overall difference between the two stents
and a low...
Study examines self-expanding plastic stents in the treatment of benign esophageal conditions
OAK BROOK, Ill. January 25, 2008 Researchers from Mayo Clinic in Rochester, Minnesota, recently examined the use of self-expanding plastic stents
(SEPSs) in the treatment of benign esophageal disease and found that use of SEPSs resulted in frequent stent migration and few cases of long-term imp...
Surgery Better Than Stents for Multiple Blockages
Fewer deaths, heart attacks found in 18-month study
WEDNESDAY, Jan. 23 (HealthDay News) -- Bypass surgery provides a lower risk of death and heart attacks than stents
for people with blockages of at least two heart arteries, a large-scale study indicates.
The finding is far from the...
Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
MADISON, Wis., Jan. 21 /PRNewswire/ -- While urinary stents
catheters can be life-saving medical devices, 40 percent of patients end up
with bacterial infections. With 100 million placed in patients each year,
this means that doctors must treat 40 million device-associated infections
Drug-Coated Stents No Riskier in Long Run Than Bare Metal Ones
Largest study to date finds no difference in heart attack or mortality rates
SUNDAY, Nov. 4 (HealthDay News) -- In the largest study of its kind to date, Harvard researchers report that they have found drug-eluting stents
pose no more risk of heart attack or death than bare metal stent...
New Canadian study finds drug coated heart stents to be safe:
'Effective in High Risk Angioplasty Patients'
TORONTO, Oct. 3 /PRNewswire/ - Much controversy has developed over the
past year about the safety and potential complications of drug-eluting
heart stents, increasing the risk of possible fatal blood clots, even years
after an angiopla...
Drug-Coated Stents Go Head to Head
Data analysis suggests sirolimus-coated model is safer
THURSDAY, Sept. 13 (HealthDay News) -- A survey of trials of drug-coated stents
finds that those coated with the medication siromilus appear to be somewhat safer than those coated with another drug, paclitaxel.
Analysis of 38 tr...
Promising Three-year Data: Saving Limbs With Drug-Eluting Stents
Interventional Radiologists Help Peripheral Arterial Disease (PAD) Patients With Critical Limb Ischemia Avoid Amputation
SAN DIEGO, March 10 /PRNewswire-USNewswire/ -- Attempts to treat critical limb ischemia in peripheral arterial disease (PAD) patients with below-the-knee angioplasty are s...
SYNTAX defines borders between CABG and PCI with TAXUS drug-eluting stents
Coronary artery bypass grafting (CABG) should remain the "standard of care" for patients with complex coronary artery disease, concludes the SYNTAX study, published in the New England Journal of Medicine (online February 18, 2009, Print edition March 5).
The SYNTAX study, led jointly by Patri...
Noninvasive screening test may detect narrowing in intracranial stents
Great advances have been made in treating blockages in the arteries of the brain using angioplasty to widen the narrowed artery and a stent to hold the artery open. However, in-stent stenosis, or a re-blockage of the artery within the stent due to scar tissue or blood clots, is estimated to occur ...
Better patient outcomes with drug eluting stents
Patients receiving drug eluting stents
coated with medication to prevent narrowing of the artery as part of an angioplasty had better outcomes one year later than patients with bare metal stents, according to a new study to be published in CMAJ http://www.cmaj.ca/press/080050.pdf...
New Drug Shows Promise in Use With Coronary Stents
Antiplatelet prasugrel may protect better than Plavix, study shows
SATURDAY, March 29 (HealthDay News) -- Treatment with a new antiplatelet drug called prasugrel may be better than standard treatment in protecting against blocked blood flow in patients with at least one coronary stent...
Experts Offer Clarity on Confusion Surrounding Stents
Amid flurry of studies, certain advice emerging for heart patients,,,,
FRIDAY, Feb. 22 (HealthDay News) -- To stent or not to stent? Which type of the artery-opening device is best? When is heart bypass surgery smarter than getting a stent?
These are the questions many heart patient...
Study looks at off-label use of biliary stents
BOSTON Although approved by the U.S. Food and Drug Administration as a palliative treatment for cancer patients who have developed bile-duct obstructions, biliary stents
are sometimes used off-label for the treatment of peripheral vascular disease (PVD). A study in todays issue of the American Jo...
Top10 research advances include studies on genetics and stem cell research, stents
Several new studies on genetics and stem cell research, along with studies that continue to debate the use of stents
to clear coronary artery blockages are among the top research advances in heart disease and stroke for 2007, said Daniel W. Jones, M.D., president of the American Heart Association....
Aeon Bioscience Continues Development of Drug Eluting Stents
BIRMINGHAM, Ala., Oct. 10 /PRNewswire-USNewswire/ -- Aeon Bioscience,
Inc. today announced the recent acquisition of one of its key
collaborators, Brookwood Pharmaceuticals, Inc. by SurModics, Inc., a major
development in its quest to develop improvements in drug-eluting stent
technology for t...
Study Finds Benefits With Drug-Coated Stents
Better outcomes for high-risk patients
WEDNESDAY, Oct. 3 (HealthDay News) -- Drug-coated stents
offered a clear advantage over the bare-metal kind for high-risk patients with blocked coronary arteries, a large Canadian study found.
The rate of restenosis -- having the artery become ...
Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
Report of Positive Results with Innovative Pro-Healing Stent is Featured at ESC Congress 2007
VIENNA, Austria, Sept. 3 /PRNewswire/ -- OrbusNeich today announced
that post-marketing data from patient subsets of a global registry support
the use of the company's Genous(T...
Nanowire coating for bone implants, stents
FAYETTEVILLE, Ark. - University of Arkansas researchers have found a simple, inexpensive way to create a nanowire coating on the surface of biocompatible titanium that can be used to create more effective surfaces for hip replacement, dental reconstruction and vascular stenting. Further, the mater...
Off-label and Untested Use of Drug-coated Stents Appears Widespread
The off-label and untested use of drug-coated stents
in the treatment of coronary artery blockage is common in U.S. practice, and ischemic complication rates are higher among patients receiving drug-coated stents
for off-label indications, according to two studies in the May 9 issue of JAMA.